A perspective on the one-year results of the Aspirin and Tranexemic Acid for Coronary Artery Surgery trial

Abstract

The 1-year results of the Aspirin and Tranexemic Acid for Coronary Artery Surgery (ATACAS) are reported. 1 They are similar to the 30-day results previously published 2 in that preoperative acetylsalicylic acid (ASA) did not reduce mortality, severe disability, or thromboembolic events